C2I Accelerator
Dr. Raj Manchanda is currently Innovation Portfolio Leader at Bill and Melinda Gates Medical Research Institute (Gates MRI) in Cambridge. Raj holds a Ph. D in Chemistry from Yale University, an M.Sc. in Chemistry from the Indian Institute of Technology, and a B.Sc. in Chemistry from Delhi University. He was also an Anna Fuller postdoctoral fellow at MIT. Previously he was at Frequency Therapeutics where he was Chief Development Officer. Prior to Frequency, Raj was VP of Neurodegeneration and Early-Stage Therapeutics at Biogen. He also held leadership positions at Diatide, Avid Radiopharmaceuticals, Perkin Elmer Life and Analytical Sciences, and URL Pharmaceuticals.
This person is not in the org chart
This person is not in any offices
C2I Accelerator
C2I Accelerator is a private chemistry-focused facility that provides a nurturing, affordable, and flexible home to regional life science entrepreneurs to launch their start-up companies, test their dreams, and develop their research technologies all with the goal of creating a greater number of successful companies, increasing jobs, strengthen the local economy and find tomorrows commercial products.